Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...